Porter AC: Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. In: J. Pharmacol. Exp. Ther. 301. Jahrgang, Nr.3, 2002, S.1020–4, doi:10.1124/jpet.301.3.1020, PMID 12023533 (aspetjournals.org).
doi.org
Porter AC: Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. In: J. Pharmacol. Exp. Ther. 301. Jahrgang, Nr.3, 2002, S.1020–4, doi:10.1124/jpet.301.3.1020, PMID 12023533 (aspetjournals.org).
nih.gov
ncbi.nlm.nih.gov
Porter AC: Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. In: J. Pharmacol. Exp. Ther. 301. Jahrgang, Nr.3, 2002, S.1020–4, doi:10.1124/jpet.301.3.1020, PMID 12023533 (aspetjournals.org).
